Neditol Xl (Tolterodine Tartrate)

Tolterodine, the active ingredient in Neditol Xl, is an antimuscarinic (anticholinergic) agent presented as an oral tablet for oral use. It is prescribed to manage symptoms of overactive bladder, including urinary urgency, frequency, and urge incontinence, in adult patients. The medication works by relaxing the bladder muscle, thereby increasing storage capacity and reducing involuntary contractions.

GNH USA supplies Neditol Xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established logistics and regulatory expertise to ensure reliable delivery across EU and other markets.

Tolterodine is used to treat conditions related to overactive bladder and urinary urgency.

- Overactive bladder: reduces episodes of urgency and improves bladder capacity. - Urinary urgency: diminishes the sudden need to void. - Urinary frequency: lowers the number of daily voids. - Urge urinary incontinence: decreases involuntary leakage episodes.

Tolterodine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: reduced salivary secretion. - Constipation: slowed gastrointestinal motility. - Blurred vision: transient visual disturbances. - Urinary retention: difficulty initiating urination. - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Angle‑closure glaucoma: sudden eye pain and visual loss. - Tachycardia: rapid heart rate requiring medical attention. - Severe constipation: risk of bowel obstruction. - Acute urinary retention: may need catheterisation.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe impairment. - Monitor for urinary retention: especially in patients with prostate enlargement. - Avoid in uncontrolled narrow‑angle glaucoma: anticholinergic effect may worsen condition. - Caution in elderly: increased anticholinergic burden may cause confusion. - Pregnancy: risk category unknown; discuss benefits and risks with a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture.

Tolterodine can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase tolterodine plasma levels. - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce therapeutic effect. - Other anticholinergic agents: additive anticholinergic burden.

Moderate Interactions (Monitor Closely):\n- Diuretics: heightened risk of urinary retention. - Beta‑agonists: possible counteraction of bladder relaxation. - Alcohol: may exacerbate dizziness and CNS effects.